RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $640,605 | +9.9% | 213,535 | -9.9% | 0.00% | – |
| Q2 2023 | $582,777 | +590.7% | 236,901 | +534.5% | 0.00% | – |
| Q1 2023 | $84,375 | +46.0% | 37,334 | +125.4% | 0.00% | – |
| Q4 2022 | $57,795 | -88.7% | 16,560 | +19.4% | 0.00% | – |
| Q3 2022 | $513,000 | +207.2% | 13,865 | +57.8% | 0.00% | – |
| Q2 2022 | $167,000 | -8.2% | 8,787 | +30.4% | 0.00% | – |
| Q1 2022 | $182,000 | -22.6% | 6,736 | -35.3% | 0.00% | – |
| Q4 2021 | $235,000 | -27.0% | 10,406 | -15.3% | 0.00% | – |
| Q3 2021 | $322,000 | +61.8% | 12,281 | +98.2% | 0.00% | – |
| Q2 2021 | $199,000 | -27.4% | 6,197 | -20.3% | 0.00% | – |
| Q1 2021 | $274,000 | +47.3% | 7,778 | +33.9% | 0.00% | – |
| Q4 2020 | $186,000 | -34.5% | 5,808 | -23.2% | 0.00% | – |
| Q3 2020 | $284,000 | -27.9% | 7,559 | -14.1% | 0.00% | – |
| Q2 2020 | $394,000 | -17.2% | 8,801 | -37.0% | 0.00% | – |
| Q1 2020 | $476,000 | – | 13,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |